Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BUFFALO, N.Y., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that the Company is scheduled to present at the Rodman and Renshaw 14th Annual Healthcare...
-
BUFFALO, N.Y., Aug. 8, 2012 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that the Company is scheduled to present at the 2012 Wedbush PacGrow Lifesciences Management...
-
BUFFALO, N.Y., Aug. 6, 2012 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today reported financial results and development progress for the second quarter ended June 30, 2012. Cleveland...
-
BUFFALO, N.Y., Aug. 1, 2012 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced the online publication of studies identifying biomarkers of CBLB502's efficacy as a radiation...
-
BUFFALO, N.Y., July 31, 2012 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that on August 6, 2012, before the market opens, it will report its second quarter financial...
-
BUFFALO, N.Y., July 30, 2012 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that, through a wholly-owned Russian subsidiary, it has signed a contract valued at 139 million...
-
BUFFALO, N.Y., July 2, 2012 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI)and its subsidiary, Incuron, LLC, announced today that a study demonstrating that CBL0137 counteracts tumor...
-
BUFFALO, N.Y., June 21, 2012 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and its subsidiary, Incuron, LLC, today announced the results of new studies demonstrating potentially curative...
-
BUFFALO, N.Y., June 18, 2012 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced the launch of an updated website emphasizing the Company's broad oncology drug pipeline. The...
-
BUFFALO, N.Y., June 14, 2012 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that the Company's Board of Directors appointed Yakov Kogan, Ph.D., MBA, as CBLI's Chief...